[1] | Sadri K, Ren Q, Zhang K, Paudyal B, Kumar D, Rodeck U, Thakur M. PET Imaging of EGFR expression in nude mice bearing MDA-MB-468, human breast adenocarcinoma. Nucl Med Commun 32:563-569, 2011. |
[2] | Thakur ML, Zhang K, Paudyal B, Devakumar D, Covarrubias MY, Cheng C, Gray BD, Wickstrom E, Pak KY. Targeting Apoptosis for Optical Imaging of Infection. Mol Imaging Biol. 2011 May 3. |
[3] | Paudyal B, Paudyal P, Oriuchi N, Hanaoka H, Tominaga H, Endo K. PET imaging and biodistribution of VEGF with 64Cu-labeled bevacizumab in colorectal cancer xenografts. Cancer Science. 102: 117-21, 2011 |
[4] | Akiyasu T, Paudyal B, Paudyal P, Yoshitaka I, Keiju H, Yoshihisa N., and Minoru K. Effectiveness of oral iron to manage anemia in long-term hemodialysis patients with the use of ultrapure dialysate, Exp Thera Med.1; 5: 777-781, 2010, DOI: 10.3892/etm.2010.122. July, 2010 |
[5] | Paudyal B, Paudyal P, Tsushima Y, Oriuchi N, Amanuma M, Miyazaki M, aketomi-Takahashi A, Nakazato Y, Endo K. The role of the ADC value in the characterisation of renal carcinoma by diffusion-weighted MRI. Br J Radiol. 83; 988: 336-343, Apr, 2010 |
[6] | Akiyasu T, Paudyal B, Paudyal P, Kumiko M, Kazue U, Takuji N, Takashi K, Yoshihisa N, Minoru K. A case report of acute renal failure associated with bee pollen contained in nutritional supplements. Ther Apher Dial.14; 1: 93-97, Feb, 2010 |
[7] | Paudyal P, Paudyal B, Hanaoka H, Oriuchi N, Iida Y, Yoshioka H, Tominaga H, Watanabe S, Watanabe S, Ishioka NS, Endo K. Imaging and biodistribution of Her2/neu expression in non-small cell lung cancer xenografts with (64)Cu-labeled trastuzumab PET. Cancer Sci. 101; 4: 1045-1050, Mar, 2010 |
[8] | Ishikita T, Oriuchi N, Higuchi T, Miyashita G, Arisaka Y, Paudyal B, Paudyal P, Hanaoka H, Miyakubo M, Nakasone Y, Negishi A, Yokoo S, Endo K. Additional value of integrated PET/CT over PET alone in the initial staging and follow up of head and neck malignancy. Ann Nucl Med. 24; 1: 77-82, Jan, 2010 |
[9] | Paudyal P, Paudyal B, Iida Y, Oriuchi N, Hanaoka H, Ishikita T, Yoshioka H, Higuchi T, and Endo K. Dual functional molecular imaging probe targeting CD20 with PET and optical imaging. Oncology Rep. 22; 1: 115-119, Jul, 2009 |
[10] | Hanaoka H, Tominaga H, Yamada K, Paudyal P, Iida Y, Watanabe S, Paudyal B, Higuchi T, Oriuchi N, Endo K. Evaluation of (64) Cu-labeled DOTA-D:-Phe (1)-Tyr (3)-octreotide (64) Cu-DOTA-TOC) for imaging somatostatin receptor-expressing tumors. Ann Nucl Med. 23; 6: 559-567, Jun, 2009 |
[11] | Miyazaki M, Tsushima Y, Miyazaki A, Paudyal B, Amanuma M, Endo K.Quantification of hepatic arterial and portal perfusion with dynamic computed tomography: comparison of maximum-slope and dual-input one-compartment model methods. Jpn J Radio. 27; 3: 143-150, April, 2009 |
[12] | Hanaoka H, Katagiri T, Fukukawa C, Yoshioka H, Yamamoto S, Iida Y, Higuchi T, Oriuchi N, Paudyal B, Paudyal P, Nakamura Y, Endo K.Radioimmunotherapy of solid tumors targeting a cell-surface protein, FZD10: therapeutic efficacy largely depends on radiosensitivity. Ann Nucl Med. 23; 5: 479-485, May, 2009 |
[13] | Paudyal B, Paudyal P, Oriuchi N, Tsushima Y, Nakajima T, Endo K. Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma. Int J Oncol. 33; 5: 1047-1054, Nov, 2008 |
[14] | Paudyal B, Oriuchi N, Paudyal P, Higuchi T, Nakajima T and Endo K. Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography. Cancer Science. 99: 2; 260-266, Feb, 2008 |
[15] | Paudyal B, Oriuchi N, Paudyal P, Tsushima Y, Higuchi T, Miyakubo M, Ishikita T, Nakajima T and Endo K. Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma. Ann Nucl Med. 22: 1; 83-86, Jan, 2008 |
[16] | Paudyal B, Oriuchi N, Paudyal P, Tsushima Y, Iida Y, Higuchi T, Hanaoka H, Miyakubo M, Takano A, Ishikita T and Endo K. Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy. Oncol Rep. 18: 6; 1469-1473, Dec, 2007 |
[17] | Miyakubo M, Oriuchi N, Tsushima Y, Higuchi T, Koyama K, Arai K, Paudyal B, Iida Y, Hanaoka H, Ishikita T, Nakasone Y, Negishi A, Mogi K and Endo K. Diagnosis of maxillofacial tumor with L-3-[18f]-fluoro-alpha-methyltyrosine (FMT) PET: a comparative study with FDG-PET. Ann Nucl Med. 21: 2; 129-135, Feb, 2007 |
[18] | Paudyal B. A case study on the effects of Iodized water consumption among high school students. Journal of Lyceum Northwestern. 4: 2, 49-54, April, 2001 |
[19] | Paudyal B, Paudyal P, Hanaoka H, Yasuhiko I, Yoshioka H, Tominaga H, Oriuchi N, and Endo K. Targeted imaging with 64Cu trastuzumab PET in non small cell lung cancer. World Journal of Nuclear Medicine, 8; 4: 257, Oct, 2009 |
[20] | Paudyal B, Paudyal P, Hanaoka H, Tominaga H, Yoshioka H, Yamamoto S, Oriuchi N, and Endo K. Radioimmuno PET imaging of vascular endothelial growth factor in colon cancer. Eur J Nucl Med Mol Imaging, 36: S2; 475, Oct, 2009 |
[21] | Paudyal B, Paudyal P, Hanaoka H, Tominaga H, Yoshioka H, Oriuchi N,and Endo K. 64Cu labeled PET for the vascular endothelial growth factor in colon cancer. Japanese Journal of Nuclear Medicine, 46: 3; 265, Sep, 2009 |
[22] | Paudyal P, Paudyal B, Oriuchi N, Iida Y, Hanaoka H, Tominaga H and Endo K. Near Infrared fluorescence imaging of angiogenesis. Japanese Journal of Nuclear Medicine, 46: 3; 265, Sep, 2009 |
[23] | Paudyal B, Paudyal P, Iida Y, Hanaoka H, Yoshioka H, Tominaga H, Oriuchi N, Higuchi T and Endo K. Potential utility of 64Cu labeled monoclonal antibody for imaging with PET. Eur J Nucl Med Mol Imaging, 35: S2; 329, Oct, 2008 |
[24] | Paudyal P, Paudyal B, Iida Y, Hanaoka H, Oriuchi N and Endo K. Multimodality Molecular Imaging of Lymphoma with Combined PET and Optical Modality. Japanese Journal of Nuclear Medicine, 45: 3; 195, Sep, 2008 |
[25] | Paudyal B, Oriuchi N, Paudyal P, Tsushima Y, Higuchi T, Miyakubo M, Nakajima T and Endo K. Glucose transporters and HK II expression in hepatocellular carcinoma compared with FDG-PET. J Nucl Med, 48: S2; 140, May, 2007 |
[26] | Paudyal B, Oriuchi N, Subedi P, Iida Y, Higuchi T, Hanaoka H, Miyakubo M, Ishikita T, Koyama J, Nakajima T and Endo K. FDG-PET and immunohistochemical staining to differentiate Hepatocellular Carcinoma and Cholangiocellular carcinoma. World Journal of Nuclear Medicine, 5: S1; 192-193, Oct, 2006 |
[27] | Paudyal B, Oriuchi N, Subedi P, Iida Y, Higuchi T, Hanaoka H, Miyakubo M, Ishikita T, Nakajima T and Endo K. Expression of Glucose Transporter-1 in Cholangiocarcinoma Compared with 18F-FDG Uptake. Japanese Journal of Nuclear Medicine, 43: 3; 226, Oct, 2006 |
[28] | Paudyal B, Oriuchi N, Subedi P, Higuchi T, Miyakubo M, Iida Y, Nakajima T and Endo K. Glucose transporters expression in hepatocellular carcinoma compared with FDG-PET. Eur J Nucl Med Mol Imaging, 33: S2; 257-258, Sep, 2006 |
[29] | Paudyal B, Oriuchi N, Miyakubo M, Iida Y, Nakajima T and Endo K. Expression of Glucose transporter in hepatocellular carcinoma compared with FDG-PET. Nippon Acta Radiologica, 25: S1; 220; Feb, 2006 |
[30] | Paudyal B, Oriuchi N, Subedi P, Higuchi T, Miyakubo M and Endo K. Correlation between FDG-PET and Alpha Fetoprotein in the Evaluation of Recurrent Hepatocellular Carcinoma Treated with Radiofrequency Ablation. Japanese Journal of Nuclear Medicine, 42: 3; 314, Sept, 2005 |
[31] | Paudyal B, Oriuchi N, Subedi P, Higuchi T, Tian M, Miyakubo M, Iida Y and Endo K. Use of FDG-PET in the evaluation of recurrent hepatocellular carcinoma treated with radiofrequency ablation. Internal Medicine Journal, 35: S1; 13, Mar, 2005 |